the market?
PLURISTEM THERAPEUTICS, INC.
NASDAQ: PSTI
3.15
0.09
(2.94%)
| Today's Open | $3.12 |
|---|---|
| Previous Close | $3.06 |
| Daily Range | $3.11 - $3.18 |
| 52-Week Range | $2.26 - $5.00 |
| Market Cap | $184.7M |
| P/E Ratio | -8.50 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 259,991 |
| Average Daily Volume | 126,141 |
| Current FY EPS | -$0.37 |
How do you think PSTI
will perform against the market?
Top PSTI Bull/Bear Pitches
jeffrycooks (< 20)
Submitted
June 3, 2011
Oppenheimer Says 5 bucks, currently in phase two- not so sure I like past behaviors of company, but they have found a worthy cause to seek treatment for with their latest procedure and phase two trial … More
zzlangerhans (< 20)
Submitted
December 14, 2011
I've made my negative feelings about Pluristem clear before, no need to reiterate everything here. The market cap has risen modestly from recent lows to 114M which gives me another opportunity to swat … More
News & Commentary
Cloning: A Stem Cell Revolution?
Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?Pluristem Gets FDA's Orphan Drug Nod for Anemia Treatment
Seven-year window of exclusivity, tax credits among benefits upon drug approval.Why Pluristem Therapeutics Is Poised to Plunge
Market-lagging returns could be written in this 1-Star.3 Horrendous Health-Care Stocks This Week
Medifast, Questcor, and Pluristem all fell.The Rosen Law Firm Announces Investigation of Securities Claims Against Pluristem Therapeutics, Inc.
Has Geron Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.The Dow's Response to These 3 Stocks: Get a Job!
These stocks just rolled over. Can they come back?Are Short-Sellers Onto Something at Pluristem Therapeutics?
Will this stock make short work of short sellers?Sector
Healthcare
Industry
Drugs
PLURISTEM THERAPEUTICS, INC. (PSTI) Description
Pluristem Therapeutic is a bio-therapeutics Company dedicated to the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative ischemic and autoimmune disorders. Website: http://www.pluristem.com/
